Related Experiment Video
Updated: Dec 21, 2025

09:03
Murine Corneal Transplantation: A Model to Study the Most Common Form of Solid Organ Transplantation
Published on: November 17, 2014
10.0K
Artificial corneas versus donor corneas for repeat corneal transplants
Masako Chen1, Sueko M Ng2, Esen K Akpek3
1Department of Ophthalmology, Icahn School of Medicine, New York Eye and Ear Infirmary of Mount Sinai, New York, 10003, USA.
The Cochrane Database of Systematic Reviews
|May 15, 2020
Summary
Repeat corneal transplantation effectiveness is unknown due to a lack of controlled trials comparing artificial (keratoprosthesis) versus donor corneas. Further research is needed to guide treatment for patients with failed corneal grafts.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Biomaterials Science
Background:
- Repeat corneal transplantation may involve artificial (keratoprosthesis) or donor corneas after failed prior grafts.
- Both procedures replace diseased, opaque corneas with new ones.
Purpose of the Study:
- To assess the effectiveness of artificial versus donor corneas for repeat corneal transplantation.
- To evaluate outcomes in patients with one or more failed donor corneal transplantations.
Main Methods:
- Comprehensive literature search of multiple databases including CENTRAL, MEDLINE, Embase, LILACS, ClinicalTrials.gov, and WHO ICTRP.
- Independent assessment of identified reports by two review authors to identify randomized controlled trials or controlled clinical trials.
- No date or language restrictions were applied to the search.
Main Results:
- No randomized controlled trials or controlled clinical trials were identified comparing artificial corneas with donor corneas for repeat corneal transplantations.
- The optimal management strategy for individuals with failed corneal transplants remains undetermined.
Conclusions:
- There is a critical lack of controlled trials comparing artificial corneal devices (e.g., Boston type 1 keratoprosthesis) with repeat donor corneal transplantation.
- Such trials are essential to guide surgeons and patients regarding visual outcomes and complications.
- Further research is needed to benefit the growing population with visual impairment due to corneal opacification.

